Barely Significant
← all excerpts

Emerging utility of once-weekly exenatide in patients with type 2 diabetes.

Diabetes Metab Syndr Obes · 2015 · PMC4621218 · PMID 26527891

Europe PMCDOI
1
hedged sentence
—
closest p
—
boldest claim

The sentences

failed to reach statistical significanceno p-value reported
Reductions in diastolic blood pressure (DBP) failed to reach statistical significance and were −0.54 mmHg (−1.15 to 0.07) compared to placebo and −0.50 mmHg (−1.24 to 0.24) compared to active control. 20 Consistent with these observations, clinically significant reductions in blood pressure were observed at week 52 (SBP: −3.6 [0.56] mmHg, P <0.0001; DBP: −1.2 [0.34] mmHg P <0.001) with weekly exenatide.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.